Search for: "Cross et al v. Merck" Results 21 - 27 of 27
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Oct 2023, 6:02 am by Bill Marler
Indeed, a principle and consistent criticism of the USDA E. coli O157:H7 policy is the fact that it has failed to focus on the risks of cross-contamination versus that posed by so-called improper cooking.[42] With this pathogen, there is ultimately no margin of error. [read post]
6 Dec 2006, 6:45 pm
Merrill et al., Eds., A Patent System for the 21st Century (National Research Council, National Academies Press, Washington, DC, 2004), pp. 25-27.What Merrill et al. said on pages 25-27 is a bit different. [read post]
30 Apr 2024, 3:12 pm by Bill Marler
Indeed, a principle and consistent criticism of the USDA E. coli O157:H7 policy is the fact that it has failed to focus on the risks of cross-contamination versus that posed by so-called improper cooking.[42] With this pathogen, there is ultimately no margin of error. [read post]
8 Jun 2024, 5:20 pm by Bill Marler
Indeed, a principle and consistent criticism of the USDA E. coli O157:H7 policy is the fact that it has failed to focus on the risks of cross-contamination versus that posed by so-called improper cooking.[42] With this pathogen, there is ultimately no margin of error. [read post]
30 Jun 2019, 11:22 am by Josh Fensterbush
United Site Services provided al…Read More » Arizona Petting Zoo 2005 Organism: E. coli O157:H7 Vehicle: Animal Contact Two children were hospitalized due to infections with an identical strain of E.coli O157:H7. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]